Key result
HCV IRES offers a potential antiviral target by driving cap-independent viral protein synthesis.
Why the study?
There is no effective treatment available for hepatitis C virus infection, and its replication depends on a unique translation-initiation mechanism involving the viral internal ribosome-entry site.
Design
Review of HCV IRES structure and translation initiation mechanism
Authors
Loading...
Hypothesis-generating for IRES-targeted antivirals in HCV; clinical trials needed before therapeutic consideration.
The hepatitis C virus internal ribosome-entry site (IRES) represents a potential target for novel antiviral therapies due to its unique role in cap-independent translation initiation.
Gallego et al. (2002) conducted a review in Hepatitis C virus infection. HCV IRES targeted antivirals was evaluated. The hepatitis C virus internal ribosome-entry site (IRES) presents a potential target for novel antiviral research due to its essential role in cap-independent initiation of viral protein synthesis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: